NCT07176429

Brief Summary

Cataract surgery involves the removal of a cloudy natural lens, followed by the implantation of an artificial lens. The choice of lens implant helps determine what the vision will be like after surgery. "Monofocal" lens implants are not designed to give both distance and close-up vision at the same time. We wish to study the amount of reading ability that a lens implant corrected for distance vision will provide. Eligible study participants include those who have had cataract surgery with implantation of either the Light Adjustable Lens® (LAL), the Light Adjustable Lens Plus® (LAL+) or the Bausch \& Lomb Akreos® AO60 lens implant. We anticipate enrolling up to 100 subjects in this study. These lens implants are designed to achieve excellent distance vision, inasmuch as the lens implant target is achieved. The lens implant target of excellent, unaided distance vision is more likely to be achieved when the chosen power of the lens implant matches the eye's curvature and length. Before cataract surgery, the eye is measured by a machine, and the information is used to calculate which lens power is predicted to best match the eye. In the case of the LAL, a light delivery device is used after surgery to fine-tune the power of the lens implant and achieve sharper unaided vision. Although both of these lens implants are technically "monofocal" lenses and work well for distance vision, they differ in ways that affect near vision. "Pseudoaccommodation" is the term that refers to the ability of an eye with a lens implant to see up close without glasses. The optical qualities of the Light Adjustable Lens generally allow eyes implanted with this lens to see objects at an intermediate or close-up range without glasses. The amount of pseudoaccommodation or close-up ability in these eyes differs from person to person. The purpose of this study is to determine the average amount of reading ability in eyes implanted with the Light Adjustable Lens® and compare it to the amount measured with the Bausch \& Lomb AO60 lens.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 10, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 16, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

September 22, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2026

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

September 16, 2025

Status Verified

September 1, 2025

Enrollment Period

6 months

First QC Date

September 10, 2025

Last Update Submit

September 10, 2025

Conditions

Keywords

Pseudoaccommodation, light adjustable lens, monofocal lens

Outcome Measures

Primary Outcomes (1)

  • Amplitude of pseudoaccommodation

    Range of near-vision as measured through best distance correction

    1 day

Study Arms (3)

Participants who have had the Light Adjustable Lens implanted with cataract surgery

Participants who have had the Light Adjustable Lens Plus implanted surgically

Device: Measurement of refractive error and amplitude of pseudoaccommodation

Participants who have had the Akreos AO60 lens implanted with cataract surgery

Device: Measurement of refractive error and amplitude of pseudoaccommodation

Participants who have had the Light Adjustable Lens Plus implanted

Device: Measurement of refractive error and amplitude of pseudoaccommodation

Interventions

We will be using an assessor, masked as to which participant received what particular lens implant to determine the range of pseudoaccommodation in each eye. This will be done for each eligible eye and the 3 cohorts will be studied and compared.

Also known as: Measurement of pupillary size, Measurement of spherical aberration of the eye
Participants who have had the Akreos AO60 lens implanted with cataract surgeryParticipants who have had the Light Adjustable Lens Plus implantedParticipants who have had the Light Adjustable Lens implanted with cataract surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Those who have had cataract surgery with the Light Adjustable Lens, the Light Adjustable Lens Plus, or the Akreos AO60 lens implant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Helm Vision Group

Valencia, California, 91355, United States

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
President, Helm Vision Group

Study Record Dates

First Submitted

September 10, 2025

First Posted

September 16, 2025

Study Start

September 22, 2025

Primary Completion

March 31, 2026

Study Completion

April 1, 2026

Last Updated

September 16, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

We can share our raw data from our spreadsheet.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
June 2026 through May 2031
Access Criteria
The PI and study coordinator will have access to the collated data on the spreadsheet.

Locations